SEC Form 4 · accession 0000899243-16-030608
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Bianco
Director
Period of report
Oct 2, 2016
Accepted (ET)
Oct 3, 2016 · 8:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $1.10 | Oct 2, 2016 | A | 2,000,000 | A | Oct 2, 2016 | Oct 14, 2018 | Common Stock | 2,000,000 | 2,000,000 | D |
| Employee Stock Option (Right to Buy) | $0.3743 | Oct 2, 2016 | A | 4,539,290 | A | Oct 2, 2016 | Oct 14, 2018 | Common Stock | 4,539,290 | 4,539,290 | D |